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Background
Assays that are used for the diagnosis and management
of HIV-1 infection are subject to assay interference(s)
and co-infection with HCV may interfere with HIV-1
genotyping and/or phenotyping. Since a third of HIV-1
infected patients are frequently HCV co-infected, there
is an increasing need to assess the effect of HCV co-
infection on the accuracy of the HIV-1 protease (PR)
and reverse transcriptase (RT) genotyping.
Purpose of the study
As a result, the efficiency and accuracy of Virco’s HIV-1
PR-RT assay performance [1] was tested on a panel of
HIV/HCV co-infected, clinical trial samples.
Materials and methods
A panel of confirmed 60 HIV/HCV-positive (Hep C
antibody +), plasma samples (screening visit), that were
collected as part of a HIV-1 clinical trial was PR-RT
genotyped (virco®TYPE HIV 1; 1497 bp encoding 1-99
amino acids of PR and 1-400 amino acids of RT), phe-
notyped (Antivirogram®) and the Clade was determined.
In addition, HCV subtyping was performed using NS5B
sequence-based subtyping [2] along with NS3/4A geno-
typing [3] in all of the tested samples. All the 60 sam-
ples tested had externally determined plasma HIV viral
loads that were >1000 copies/mL.
Results
For the 60 HIV/HCV + samples tested, the HIV PR-RT
target genes were successfully (100%) genotyped, pheno-
typed and were confirmed to be Clade B. Subtyping
(329 bp conserved fragment within NS5B) and genotyp-
ing (NS3/4A gene) of the HCV target genes was suc-
cessful for 49/60 samples (81.6%) and 33 samples were
identified as Genotype 1a, 10 samples as 1b, 5 samples
as 2b and 1 as genotype 4a.
Conclusions
We demonstrated that there is no assay interference for
HIV-1 genotyping/phenotyping in the presence of an
active HCV co-infection. The HIV-1 PR-RT primers
used within our certified, high-throughput laboratory is
highly sensitive, specific, accurate and reliable to detect
HIV-1 clade, genotype and phenotype in HIV/HCV co-
infected samples.
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